Log In
BCIQ
Print this Print this
 

VP1-001

  Manage Alerts
Collapse Summary General Information
Company ViewPoint Therapeutics
DescriptionSmall molecule stabilizer of alpha-crystallin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCataract
Indication DetailsTreat age-related cataracts
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today